NewslettersIntestinal Cell NewsAssociation of CDX2 and Mucin Expression with Chemotherapeutic Benefits in Patients with Stage II/III Gastric CancerBy Jamie Kang - August 24, 20230201Scientists assessed the ability of CDX2 and mucin markers to predict prognosis and fluorouracil-based adjuvant chemotherapy benefits.[Cancer Medicine]Full Article